12-66145944-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016056.4(TMBIM4):c.361G>A(p.Val121Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000033 in 1,545,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016056.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMBIM4 | NM_016056.4 | c.361G>A | p.Val121Ile | missense_variant | 5/7 | ENST00000358230.8 | NP_057140.2 | |
TMBIM4 | NM_001282606.2 | c.502G>A | p.Val168Ile | missense_variant | 6/8 | NP_001269535.1 | ||
TMBIM4 | NM_001282610.2 | c.268G>A | p.Val90Ile | missense_variant | 5/7 | NP_001269539.1 | ||
TMBIM4 | NM_001282609.2 | c.361G>A | p.Val121Ile | missense_variant | 5/7 | NP_001269538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMBIM4 | ENST00000358230.8 | c.361G>A | p.Val121Ile | missense_variant | 5/7 | 1 | NM_016056.4 | ENSP00000350965 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000288 AC: 7AN: 242842Hom.: 0 AF XY: 0.00000757 AC XY: 1AN XY: 132098
GnomAD4 exome AF: 0.0000359 AC: 50AN: 1393650Hom.: 0 Cov.: 23 AF XY: 0.0000330 AC XY: 23AN XY: 697366
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.361G>A (p.V121I) alteration is located in exon 5 (coding exon 5) of the TMBIM4 gene. This alteration results from a G to A substitution at nucleotide position 361, causing the valine (V) at amino acid position 121 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at